Accessibility Tools
Invert colors
Monochrome
Dark contrast
Light contrast
Low saturation
High saturation
Highlight links
Highlight headings
Screen reader
Read mode
Content scaling
100
%
Font size
100
%
Line height
100
%
Letter spacing
100
%
(678) 384-7220
info@geovax.com
About Us
Company
Leadership
Board of Directors & Corporate Advisors
Scientific Advisory Board
Collaborators
Technology
MVA Technology Overview
Gedeptin® Technology Overview
Publications
Pipeline
Pipeline Summary
Oncology
Infectious Diseases
Clinical Trials
Investors
Corporate Profile
Press Releases
Media
Events & Presentations
SEC Filings
GeoVax Stock Information
Corporate Governance
Analyst Coverage
Investor FAQ's
Careers
Contact
Leadership
David A. Dodd
Chairman, President & CEO
Arban Domi, PhD
Director, Vector Development
Mary J. Hauser, PhD
Director, Preclinical Research
Susan Hensley, MS, RAC
VP, Regulatory Affairs
Kelly T. McKee, Jr., MD, MPH
Chief Medical Officer
Mark J. Newman, PhD
Chief Scientific Officer
John Niles
Head, Commercial Operations
Thomas O’Brien
VP, Quality Systems and Compliance
Sreenivasa R. Oruganti, PhD
Senior Scientist
J. Marc Pipas, MD
Executive Medical Director, Oncology
Erica Raiden
Director, Clinical Operations
Mark W. Reynolds
Chief Financial Officer
John W. Sharkey, PhD
VP, Business Development
Jeff Welch
Head, Process Development and MFG
Ashley Zuniga, PhD, PMP
Director, Project Management
1
29
31
38
13
17
26
27
32
36
33
2
23
28
34
About GeoVax
Company
Leadership
Board of Directors & Corporate Advisors
Scientific Advisory Board
Collaborators
Our Technology
Technology
MVA Technology Overview
Gedeptin® Technology Overview
Publications
Product Pipeline
Pipeline Summary
Oncology
Infectious Diseases
Investors
Corporate Profile
News
Events & Presentations
SEC Filings
GeoVax Stock Information
Corporate Governance
Analyst Coverage
Investor FAQ's
SUBSCRIBE FOR UPDATES FROM GEOVAX
Register to receive email alerts for GeoVax press releases
SUBMIT
Last Name
About Us
Company
Leadership
Board of Directors & Corporate Advisors
Scientific Advisory Board
Collaborators
Technology
MVA Technology Overview
Gedeptin® Technology Overview
Publications
Pipeline
Pipeline Summary
Oncology
Infectious Diseases
Clinical Trials
Investors
Corporate Profile
Press Releases
Media
Events & Presentations
SEC Filings
GeoVax Stock Information
Corporate Governance
Analyst Coverage
Investor FAQ's
Careers
Contact
Search